Early adverse drug event signal detection within population‐based health networks using sequential methods: key methodologic considerations

Abstract

This paper provides additional preliminary information related to conducting prospective safety monitoring using health plan data and sequential analytic methods. Our findings support continued investigation of using health plan data and sequential analytic methods as a potentially important contribution to active drug safety surveillance.